Assignee
GC CELL CORP
KR·8 granted patents·8 pending applications·9 citations·filing 2018–2025
Top patents by PatentIndex Score
16 records- 0192US11970547B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2023·Granted Apr 30, 2024·2 cites·21 claims
- 0292US11649294B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2020·Granted May 16, 2023·3 cites·24 claims
- 0386US12116417B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2018·Granted Oct 15, 2024·2 cites·24 claims
- 0486US11766456B2Method for culturing natural killer cells using T cellsGC CELL CORP·Filed 2021·Granted Sep 26, 2023·2 cites·14 claims
- 0585US12410261B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2024·Granted Sep 9, 2025·0 cites·20 claims
- 0684US2026028418A1Anti-her2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2025·Application pending·0 cites
- 0781US2024409665A1Anti-her2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2024·Application pending·0 cites
- 0871US2025109380A1Method for culturing natural killer cell, using transformed t cellGC CELL CORP·Filed 2024·Application pending·0 cites
- 0971US2024050478A1Method for Culturing Natural Killer Cells Using T CellsGC CELL CORP·Filed 2023·Application pending·0 cites
- 1067US12435118B2Chimeric antigen receptor and natural killer cells expressing sameGC CELL CORP·Filed 2022·Granted Oct 7, 2025·0 cites·5 claims
- 1165US2023108578A1Medium Composition for Cryopreservation of Cell and Use ThereofGC CELL CORP·Filed 2022·Application pending·0 cites
- 1262US2025243461A1Method for introducing target gene into immune cellsGC CELL CORP·Filed 2023·Application pending·0 cites
- 1360US12203065B2Method for culturing natural killer cell, using transformed T cellGC CELL CORP·Filed 2018·Granted Jan 21, 2025·0 cites·30 claims
- 1458US2025282845A1Fusion proteins comprising chimeric antigen receptors and il-15GC CELL CORP·Filed 2022·Application pending·0 cites
- 1553US2023242894A1Novel transplantation cells having reduced immunogenicityGC CELL CORP·Filed 2021·Application pending·0 cites
- 1651US12491244B2Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and natural killer cellGC CELL CORP·Filed 2019·Granted Dec 9, 2025·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when GC CELL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →